Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
Authors
Keywords
Dual topoisomerase inhibitor, Topoisomerase2α, G2/M arrest, DNA breakage, YAP1
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-04
DOI
10.1186/s13046-018-0759-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of YAP Inhibition on Human Leukemia HL-60 Cells
- (2017) Min Chen et al. International Journal of Medical Sciences
- Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways
- (2017) Yong Wen et al. International Journal of Medical Sciences
- Phosphorylation by NLK inhibits YAP‐14‐3‐3‐interactions and induces its nuclear localization
- (2016) Sungho Moon et al. EMBO REPORTS
- Sophoridinol derivative 05D induces tumor cells apoptosis by topoisomerase1-mediated DNA breakage
- (2016) Wuli Zhao et al. OncoTargets and Therapy
- p53 in the DNA-Damage-Repair Process
- (2016) Ashley B. Williams et al. Cold Spring Harbor Perspectives in Medicine
- YAP Regulates S-Phase Entry in Endothelial Cells
- (2015) Zhewei Shen et al. PLoS One
- CFAssay: statistical analysis of the colony formation assay
- (2015) Herbert Braselmann et al. Radiation Oncology
- Brief Reports: Controlling the Survival of Human Pluripotent Stem Cells by Small Molecule-Based Targeting of Topoisomerase IIAlpha
- (2015) Uri Ben-David et al. STEM CELLS
- The dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religation
- (2015) Wuli Zhao et al. Oncotarget
- YAP controls retinal stem cell DNA replication timing and genomic stability
- (2015) Pauline Cabochette et al. eLife
- c-Abl antagonizes the YAP oncogenic function
- (2014) R Keshet et al. CELL DEATH AND DIFFERENTIATION
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
- (2014) Francesca Cottini et al. NATURE MEDICINE
- Topoisomerase IIα in chromosome instability and personalized cancer therapy
- (2014) T Chen et al. ONCOGENE
- CDK1 Phosphorylation of YAP Promotes Mitotic Defects and Cell Motility and Is Essential for Neoplastic Transformation
- (2013) S. Yang et al. CANCER RESEARCH
- Myofibrillogenesis regulator-1 promotes cell adhesion and migration in human hepatoma cells
- (2013) WuLi Zhao et al. CHINESE SCIENCE BULLETIN
- Discovery, synthesis and biological evaluation of cycloprotoberberine derivatives as potential antitumor agents
- (2013) Yang-Biao Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation
- (2013) W Zhao et al. Blood Cancer Journal
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
- (2008) Jiahao Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screening
- (2008) David Katz et al. BIOTECHNIQUES
- Mitotic catastrophe is the predominant response to histone acetyltransferase depletion
- (2008) G-H Ha et al. CELL DEATH AND DIFFERENTIATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started